IHC of paraffin-embedded pancreas tissue using anti-SORD mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Ovary tissue using anti-SORD mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Carcinoma of thyroid tissue using anti-SORD mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded prostate tissue using anti-SORD mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded endometrium tissue using anti-SORD mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Carcinoma of bladder tissue using anti-SORD mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded breast tissue using anti-SORD mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Kidney tissue using anti-SORD mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Adenocarcinoma of colon tissue using anti-SORD mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded colon tissue using anti-SORD mouse monoclonal antibody. (Dilution 1:50).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SORD (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SORD.
Western blot of extracts (35 ug) from 9 different cell lines by using anti-SORD monoclonal antibody.